Advanced Biomed Inc.
ADVB
$0.59
$0.1328.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.30% | -52.43% | -241.83% | 67.19% | 23.37% |
| Total Depreciation and Amortization | -17.54% | -21.19% | -3.03% | -33.59% | 85.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 56.90% | -6,275.15% | -124.68% | -25.56% | 294.37% |
| Cash from Operations | 54.72% | -305.04% | -2,734.34% | 93.76% | 55.35% |
| Capital Expenditure | -813.64% | -120.56% | 153.50% | 62.48% | -299.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -813.64% | -120.56% | 153.50% | 62.48% | -299.63% |
| Total Debt Issued | -31.29% | -38.13% | 3.86% | 0.10% | -22.64% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -199.40% | 33,647.62% | 0.00% | 80.33% | -354.17% |
| Cash from Financing | -112.98% | 1,344.77% | 4.03% | 21.33% | -42.46% |
| Foreign Exchange rate Adjustments | 24.43% | -90.83% | 242.56% | -302.80% | -58.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.24% | 24,673.53% | -73.85% | 170.02% | 50.66% |